A detailed history of Core Cap Advisors, LLC transactions in Cerus Corp stock. As of the latest transaction made, Core Cap Advisors, LLC holds 1,000 shares of CERS stock, worth $1,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$1,660
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.7 - $2.39 $1,700 - $2,390
1,000 New
1,000 $1,000
Q1 2024

Aug 08, 2024

BUY
$1.66 - $2.42 $2,324 - $3,388
1,400 New
1,400 $2,000
Q4 2022

Feb 10, 2023

BUY
$3.38 - $4.22 $3,380 - $4,220
1,000 New
1,000 $3,000
Q2 2022

Aug 11, 2022

BUY
$4.41 - $5.69 $4,410 - $5,690
1,000 New
1,000 $5,000
Q1 2022

Apr 29, 2022

SELL
$4.81 - $6.99 $4,810 - $6,990
-1,000 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$5.97 - $7.93 $5,970 - $7,930
1,000 New
1,000 $7,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.